Our approach to government and national security partnerships
Learn how OpenAI approaches government and national security partnerships, with principles for responsible AI use, democratic accountability, and public safety.
Updated 1 min ago · 788 articles from OpenAI Blog
Learn how OpenAI approaches government and national security partnerships, with principles for responsible AI use, democratic accountability, and public safety.
OpenAI Academy and the Walton Family Foundation are bringing hands-on AI Skills Jams to help K–12 educators build practical AI skills for the classroom.
See how Australian Payments Plus uses ChatGPT Enterprise and Codex to move faster through payments complexity. AP+ saves time, improves quality, and keeps hu...
MUFG uses ChatGPT Enterprise to build an AI-native organization, improve workflows, and deliver new AI-powered financial services at scale.
New OpenAI Signals data shows how ChatGPT adoption is growing globally, with users increasing usage, exploring more capabilities, and driving growth across r...
OpenAI engineers used large-scale core dump analysis to debug rare infrastructure crashes, uncovering both a hardware fault and a long-standing software bug.
A new OpenAI report maps how AI could reshape jobs across the EU, highlighting which occupations may face automation, growth, or workflow changes.
HP Inc. scales its OpenAI Frontier partnership to deploy AI across customer experiences, software development, and enterprise operations.
OpenAI previews GPT-5.6 Sol, a next-generation model with stronger capabilities in coding, science, and cybersecurity, paired with its most advanced safety s...
A new OpenAI research paper shows how AI agents are transforming work, enabling longer, more complex tasks and expanding productivity across roles.
OpenAI and Broadcom introduce Jalapeño, a custom AI chip built for LLM inference to improve performance, efficiency, and scale across AI systems.
GPT-5 Pro helped solve a 3-year-old immunology mystery, offering insights into T cell behavior. The breakthrough could support cancer and autoimmune research.